Discovery and Characterization of the First Highly Potent and Selective AXL Receptor Tyrosine Kinase Inhibitor AB801
MOLECULAR CANCER THERAPEUTICS(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined